arrow_back Back to App

Medicare to fully cover lung cancer biomarker testing starting 2027.

This bill mandates that the Medicare program must fully cover advanced biomarker testing for individuals diagnosed with lung cancer, effective January 1, 2027. This change ensures that Medicare beneficiaries will face zero out-of-pocket costs for these precise diagnostic tests, which are essential for determining personalized treatment strategies. The goal is to improve access to cutting-edge cancer care.
Key points
Medicare coverage is required for lung cancer biomarker testing (analyzing genes, proteins, or molecules).
Beneficiaries will pay nothing; the coverage rate is 100% of the reasonable charges for the testing.
The new coverage requirement takes effect on January 1, 2027.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6321
Sponsor: Rep. Gottheimer, Josh [D-NJ-5]
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Lung Cancer Medicare Access to Precise Testing Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_6321.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What are the main provisions?

Key points include:

  • Medicare coverage is required for lung cancer biomarker testing (analyzing genes, proteins, or molecules).
  • Beneficiaries will pay nothing; the coverage rate is 100% of the reasonable charges for the testing.
  • The new coverage requirement takes effect on January 1, 2027.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gottheimer, Josh [D-NJ-5].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Benefits